Does endotoxin-activated complement alter myocellular sodium homeostasis during sepsis?

BACKGROUND Inappropriate complement activation is closely related to tissue injury and organ dysfunction during systemic infection. It is not clear, however, if endotoxin-induced complement activation is responsible for changes in myocellular sodium homeostasis during sepsis. METHODS Rats underwent cecal ligation and puncture (CLP) or sham operation. Twenty-four hours after operation, fast-twitch extensor digitorum longus (EDL) muscles were isolated, incubated at 30 degrees C for 1 hour in Krebs-Henseleit buffer (KHB) (pH 7.4), and used to measure intracellular Na+ and K+ contents. Blood samples were collected to measure serum hemolytic complement activity and endotoxin levels. In addition, EDL muscles isolated from normal animals were incubated at 30 degrees C for 1 hour with zymosan-activated (10 mg/mL at 37 degrees C for 1 hour) rat sera, with lipopolysaccharide (LPS)-activated (LPS from Escherichia coli 055:B5, 10 or 200 microg/mL at 37 degrees C for 30 minutes) rat sera, with heat-inactivated (56 degrees C for 30 minutes) rat sera, with LPS (1 or 20 microg/mL), or in KHB. EDL muscles isolated from normal animals were also incubated with septic sera collected 6 or 24 hours after CLP with or without administration of soluble complement receptor type 1 (20 mg/kg, intraperitoneally). Myocellular Na+ and K+ contents ([Na+]i and [K+]i) were assayed using "washout" technique. Soluble C5b-9 complex levels in zymosan-activated or LPS-activated human sera were determined by enzyme-linked immunosorbent assay to evaluate the degree of complement activation induced by zymosan or LPS. RESULTS Myocellular [Na+]i and [Na+]i/[K+]i ratios increased significantly 24 hours after CLP as compared with sham operation and were associated with decreased serum hemolytic complement activity and increased serum endotoxin levels. Zymosan-activated rat sera at sublytic concentrations markedly increased [Na+]i and [Na+]i/[K+]i ratios in isolated EDL muscles relative to heat-inactivated rat sera. LPS-activated rat sera, however, did not alter these two indices. In addition, myocellular [Na+]i and [Na+]i/[K+]i ratios were equivalent among normal EDL muscles incubated with septic sera, soluble complement receptor type 1-treated septic sera, or KHB. CONCLUSION These results collectively suggest that polymicrobial sepsis, as produced by CLP, alters sodium homeostasis in fast-twitch skeletal muscles in association with changes in systemic complement activation and circulating endotoxin levels. Although endotoxin can activate the complement cascade, endotoxin-induced complement activation does not appear to be responsible for changes in myocellular sodium homeostasis observed during sepsis in rats.

[1]  R. Barrington,et al.  The role of complement in inflammation and adaptive immunity , 2001, Immunological reviews.

[2]  D. Jacobs,et al.  In vitro complement activation favoring soluble C5b-9 complex formation alters myocellular sodium homeostasis. , 2001, Surgery.

[3]  V. M. Holers,et al.  Complement is activated in kidney by endotoxin but does not cause the ensuing acute renal failure. , 2000, Kidney international.

[4]  I. Chaudry,et al.  Immune depression in polymicrobial sepsis: The role of necrotic (injured) tissue and endotoxin , 2000, Critical care medicine.

[5]  D. Jacobs,et al.  Sublytic complement attack increases intracellular sodium in rat skeletal muscle. , 2000, The Journal of surgical research.

[6]  Z. Fishelson,et al.  Cell desensitization by sublytic C5b‐9 complexes and calcium ionophores depends on activation of protein kinase C , 2000, European journal of immunology.

[7]  B. Holzmann,et al.  Endotoxin-Induced Lung Inflammation Is Independent of the Complement Membrane Attack Complex , 2000, Infection and Immunity.

[8]  T. Ninomiya,et al.  Sodium overload through voltage-dependent Na+ channels induces necrosis and apoptosis of rat superior cervical ganglion cells in vitro , 2000, Brain Research Bulletin.

[9]  L. Larsson,et al.  Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: Mechanisms at the cellular and molecular levels , 2000, Critical care medicine.

[10]  E. Hund Myopathy in critically ill patients. , 1999, Critical care medicine.

[11]  H. Rus,et al.  Complement activation and atherosclerosis. , 1999, Molecular immunology.

[12]  Z. Fishelson,et al.  Complement resistance of tumor cells: basal and induced mechanisms. , 1999, Molecular immunology.

[13]  S. V. Kotelevtsev,et al.  Inversion of the Intracellular Na+/K+Ratio Blocks Apoptosis in Vascular Smooth Muscle at a Site Upstream of Caspase-3* , 1999, The Journal of Biological Chemistry.

[14]  Jianzhu Chen,et al.  A Critical Role of Natural Immunoglobulin M in Immediate Defense Against Systemic Bacterial Infection , 1998, The Journal of experimental medicine.

[15]  M. Ferretti,et al.  Heterotrimeric G proteins physically associated with the lipopolysaccharide receptor CD14 modulate both in vivo and in vitro responses to lipopolysaccharide. , 1998, The Journal of clinical investigation.

[16]  Schlag,et al.  Anti‐TNF Treatment of Baboons with Sepsis Reduces TNF‐α, IL‐6 and IL‐8, but not the Degree of Complement Activation , 1998, Scandinavian journal of immunology.

[17]  W. Hop,et al.  Complement Activation in Relation to Capillary Leakage in Children with Septic Shock and Purpura , 1998, Infection and Immunity.

[18]  P. Póvoa,et al.  C-reactive protein as an indicator of sepsis , 1998, Intensive Care Medicine.

[19]  J. Papillon,et al.  Complement activates phospholipases and protein kinases in glomerular epithelial cells. , 1998, Kidney international.

[20]  C. Hack,et al.  Effect of C1 inhibitor on inflammatory and physiologic response patterns in primates suffering from lethal septic shock. , 1998, Journal of immunology.

[21]  C. Bortner,et al.  A Primary Role for K+ and Na+ Efflux in the Activation of Apoptosis* , 1997, The Journal of Biological Chemistry.

[22]  T. Badea,et al.  Sublytic Terminal Complement Attack on Myotubes Decreases the Expression of mRNAs Encoding Muscle‐Specific Proteins , 1997, Journal of neurochemistry.

[23]  P. Gasque,et al.  Human skeletal myoblasts spontaneously activate allogeneic complement but are resistant to killing. , 1996, Journal of immunology.

[24]  M. Rich,et al.  Muscle is electrically inexcitable in acute quadriplegic myopathy , 1996, Neurology.

[25]  E. Gelfand,et al.  Ouabain induces inhibition of the progression phase in human T‐cell proliferation , 1995, Journal of cellular physiology.

[26]  S. Greenberg,et al.  Soluble Ligands of the αvβ4 Integrin Mediate Enhanced Tyrosine Phosphorylation of Multiple Proteins in Adherent Bovine Pulmonary Artery Endothelial Cells (*) , 1995, The Journal of Biological Chemistry.

[27]  H. Lassmann,et al.  Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis. , 1994, Journal of immunology.

[28]  C. Hack,et al.  Activation of the complement system in baboons challenged with live Escherichia coli: correlation with mortality and evidence for a biphasic activation pattern , 1993, Infection and immunity.

[29]  R. Latimer,et al.  Endotoxin‐induced organ injury , 1993, Critical care medicine.

[30]  M. Everts,et al.  Activation of the Na-K pump by intracellular Na in rat slow- and fast-twitch muscle. , 1992, Acta physiologica Scandinavica.

[31]  B. Lucchesi,et al.  Effects of complement activation in the isolated heart. Role of the terminal complement components. , 1992, Circulation research.

[32]  C. Dinarello,et al.  Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia. Comparison to Escherichia coli. , 1991, The Journal of clinical investigation.

[33]  C. Natanson,et al.  Pseudomonas aeruginosa compared with Escherichia coli produces less endotoxemia but more cardiovascular dysfunction and mortality in a canine model of septic shock. , 1990, Chest.

[34]  T. Hugli,et al.  Endotoxin-induced shock in the rat. A role for C5a. , 1989, The American journal of pathology.

[35]  C. Natanson,et al.  Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock. , 1989, The Journal of clinical investigation.

[36]  P. Little,et al.  The effects of alterations in membrane sodium transport on rat aortic smooth muscle proliferation , 1988, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[37]  D. Tosteson,et al.  Complement induces a transient increase in membrane permeability in unlysed erythrocytes. , 1988, The Journal of clinical investigation.

[38]  J. Tomás,et al.  Role of lipopolysaccharide and complement in susceptibility of Escherichia coli and Salmonella typhimurium to non-immune serum. , 1988, Journal of general microbiology.

[39]  T. Mollnes,et al.  Terminal complement complexes and anaphylatoxins in septic and ischemic patients. , 1988, Archives of surgery.

[40]  B. Warner,et al.  Reduced muscle amino acid uptake in sepsis and the effects in vitro of septic plasma and interleukin-1. , 1986, Surgery.

[41]  T. Raffin,et al.  Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates. , 1986, The Journal of clinical investigation.

[42]  L. Kline,et al.  Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS). , 1977, Journal of immunology.

[43]  Morgan Bp Regulation of the complement membrane attack pathway. , 1999 .

[44]  C. Hack,et al.  Complement activation in patients with sepsis is in part mediated by C-reactive protein. , 1998, The Journal of infectious diseases.

[45]  J. Bhattacharya,et al.  Soluble complex of complement increases hydraulic conductivity in single microvessels of rat lung. , 1993, The Journal of clinical investigation.

[46]  J. Halperin,et al.  Membrane signaling by complement C5b-9, the membrane attack complex , 1993, Immunologic research.

[47]  M. Rynkiewicz,et al.  Transient changes in erythrocyte membrane permeability are induced by sublytic amounts of the complement membrane attack complex (C5b-9). , 1993, Blood.

[48]  G. Shires,et al.  Assessment of the early cellular membrane response to live Escherichia coli bacteremia. , 1989, The Journal of surgical research.

[49]  C. Hack,et al.  Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis. , 1989, The American journal of medicine.

[50]  M. Shin,et al.  Cytotoxic Action and Other Metabolic Consequences of Terminal Complement Proteins , 1988 .